Compared with participants without endpoints, participants with an endpoint event had higher BMI and greater proportions of diabetes, previous MI, previous PCI, multi-vessel CAD, and use of insulin and oral hypoglycemic drugs (all P < 0.05). The gene discussed is INS; the disease is coronary artery disorder.